tiprankstipranks
Nexalin Technology files to sell 2.8M shares of common stock for holders
PremiumThe FlyNexalin Technology files to sell 2.8M shares of common stock for holders
2M ago
Nexalin Technology downgraded to Hold from Buy at Maxim
Premium
The Fly
Nexalin Technology downgraded to Hold from Buy at Maxim
3M ago
Nexalin Technology announces peer-reviewed publication on DIFS technology
Premium
The Fly
Nexalin Technology announces peer-reviewed publication on DIFS technology
3M ago
Nexalin announced planned clinical trial utilizing Gen-3 Halo headset
PremiumThe FlyNexalin announced planned clinical trial utilizing Gen-3 Halo headset
4M ago
Nexalin Technology announces results from trial using its DIFS technology
Premium
The Fly
Nexalin Technology announces results from trial using its DIFS technology
4M ago
Nexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs
Premium
The Fly
Nexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs
4M ago
Nexalin selected to join Breaking Barriers to Substance Use Recovery coalition
PremiumThe FlyNexalin selected to join Breaking Barriers to Substance Use Recovery coalition
7M ago
Nexalin Technology 3M share Spot Secondary priced at $1.75
Premium
The Fly
Nexalin Technology 3M share Spot Secondary priced at $1.75
8M ago
Nexalin Technology announces ‘positive’ study data in MDD
Premium
The Fly
Nexalin Technology announces ‘positive’ study data in MDD
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100